Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a period of time at Harvard Medical School looking at the cause of cardiovascular diseases and a year at Johns Hopkins Medical School looking at the treatment of liver. He published more than 647 peer-reviewed research papers and registered 14 UK and International patents. He is currently CEO of NanoRegMed Ltd, working on the commercialization of his research. During his career, Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialization and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”. Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include the development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. He has over 15,000 media report from his achievement, include BBC, ITV, WSJ, CNN, and many more. Currently, he is working on the development and commercialization of human organs using graphene-based nanocomposite materials and stem cells technology.
Stem cells, Bio-materials and Regenerative medicine
Majid Ghassemi is a Professor of Mechanical Engineering Department at the K. N. Toosi University of Technology in Tehran, Iran. He has over 20 years of academic and industrial experience and served as the President of the K. N. Toosi University of Technology from 2010 through 2013. Professor Ghassemi has also served in several public and private boards and panels and supervised several undergraduate, masters and PhD students, published several books and many journal and conference papers. He is currently Editor-in-Chief and Editorial Board member for many international journals. He also serves as member in several international conferences. Professor Ghassemi received his Ph.D. in Mechanical Engineering from Iowa State University in 1993.
Biosensors, Drug Delivery in Biomedical Engineering - Targeted Drug Delivery to Cardiac Tissue using Magnetic and Electromagnetic Field
Mohamed Abd Ellatif Mohamed Said completed his studies at Mansoura University (1985-1995), Toronto University (2001). Then he went back to Mansoura University and joined as a Professor in Medical Biochemistry and Molecular Biology, Faculty of Medicine. In 2007 he joined as a professor of Clinical Biochemistry and Molecular Biology, College of Medicine, King Khalid University, Kingdom of Saudi Arabia during the period from 2/9/2007 till now. He has more than 55 research papers in national and international journals. He attended more than 43 international and national workshops and conferences. He is an active reviewer for many scientific journals and conferences. He handled 8 master thesis and 7 Ph.D. thesis.
Medical Biochemistry, Clinical Biochemistry, Molecular biology and Bio medicine